Table 1.
A Summary of Maternal and Neonatal Outcomes Infected With COVID-19
Case No. | 1 | 2 | 3 | n/N (%) |
---|---|---|---|---|
Maternal and neonatal outcomes | ||||
Age, y | 28 | 33 | 27 | … |
Gravida (G) and para (P) | G1, P1 | G1, P1 | G1, P1 | … |
Gestational age on admission, weeks+days | 34+6 | 39+1 | 38+2 | … |
Mode of delivery | ||||
Vaginal route | Yes | Yes | Yes | 3/3 (100) |
Sign and symptoms | ||||
Fever | Yes | Yes | No | 2/3 (66.6) |
Cough | Yes | Yes | Yes | 3/3 (100) |
Chest tightness | No | No | Yes | 1/3 (33.3) |
Infected with SARS-Cov-2 | Yes | Yes | Yes | 3/3 (100) |
Laboratory results | ||||
White blood cell count (×109 cells per L) | 7.5 | 11.7 | 12.9 | … |
Lymphocyte count (×109 cells per L) | 1.1 | 2.76 | 1.06 | … |
C-reactive protein (mg/L) | 32 | 18.4 | 1.5 | … |
ALT (U/L) | 10 | 16 | 6 | … |
AST (U/L) | 30 | 27 | 13 | … |
Neonatal outcomes | … | |||
Apgar score, 1 min–5 min | 8–9 | 9–10 | 9–10 | … |
Birth weight, g | 2,890 | 3,500 | 3,730 | … |
Birth length, cm | 48 | 50 | 51 | … |
Preterm delivery | Yes | No | No | 1/3 (33.3) |
Neonatal death/still birth | No | No | No | 0/3 (0.00) |
Infected with SARS-Cov-2 | No | No | No | 0/3 (0.00) |
Note. ALT, alanine aminotransferase; AST, aspartate aminotransferase.